MYCN Polyclonal Antibody

This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. Amplification of this gene is associated with a variety of tumors, most notably neuroblastomas. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

The MYCN Polyclonal Antibody is a highly specific and sensitive antibody that has been designed to detect the MYCN protein in various biological samples. This antibody has been extensively validated for use in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The MYCN protein is a transcription factor that plays a critical role in the regulation of cell growth and differentiation. Aberrant expression of MYCN has been implicated in the development and progression of various types of cancer, including neuroblastoma, small cell lung cancer, and medulloblastoma. Therefore, the MYCN Polyclonal Antibody is an essential tool for researchers studying the role of MYCN in cancer biology.

The MYCN Polyclonal Antibody has been produced using high-quality materials and state-of-the-art techniques to ensure maximum specificity and sensitivity. This antibody has been rigorously tested to ensure that it meets the highest standards of quality and performance.

In summary, the MYCN Polyclonal Antibody is a reliable and effective tool for researchers studying the role of MYCN in cancer biology. Its high specificity and sensitivity make it an essential tool for the detection and quantification of MYCN protein in various biological samples.